Logo image of PL

PLANET LABS PBC (PL) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PL - US72703X1063 - Common Stock

19.36 USD
-0.96 (-4.72%)
Last: 12/26/2025, 8:10:09 PM
19.25 USD
-0.11 (-0.57%)
After Hours: 12/26/2025, 8:10:09 PM
Fundamental Rating

3

Overall PL gets a fundamental rating of 3 out of 10. We evaluated PL against 86 industry peers in the Professional Services industry. While PL seems to be doing ok healthwise, there are quite some concerns on its profitability. PL shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year PL has reported negative net income.
PL had a positive operating cash flow in the past year.
In the past 5 years PL always reported negative net income.
In the past 5 years PL always reported negative operating cash flow.
PL Yearly Net Income VS EBIT VS OCF VS FCFPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

PL has a Return On Assets of -11.71%. This is in the lower half of the industry: PL underperforms 75.58% of its industry peers.
The Return On Equity of PL (-37.06%) is worse than 76.74% of its industry peers.
Industry RankSector Rank
ROA -11.71%
ROE -37.06%
ROIC N/A
ROA(3y)-20.33%
ROA(5y)-21.9%
ROE(3y)-27.72%
ROE(5y)-44.51%
ROIC(3y)N/A
ROIC(5y)N/A
PL Yearly ROA, ROE, ROICPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

PL has a Gross Margin of 57.95%. This is in the better half of the industry: PL outperforms 75.58% of its industry peers.
PL's Gross Margin has improved in the last couple of years.
PL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.26%
GM growth 5YN/A
PL Yearly Profit, Operating, Gross MarginsPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100

5

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PL has more shares outstanding
Compared to 5 years ago, PL has more shares outstanding
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PL Yearly Shares OutstandingPL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
PL Yearly Total Debt VS Total AssetsPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

PL has an Altman-Z score of 3.96. This indicates that PL is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.96, PL is doing good in the industry, outperforming 74.42% of the companies in the same industry.
The Debt to FCF ratio of PL is 12.76, which is on the high side as it means it would take PL, 12.76 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.76, PL is in line with its industry, outperforming 43.02% of the companies in the same industry.
PL has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.28, PL is doing worse than 74.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 12.76
Altman-Z 3.96
ROIC/WACCN/A
WACC8.79%
PL Yearly LT Debt VS Equity VS FCFPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

PL has a Current Ratio of 4.00. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.00, PL belongs to the best of the industry, outperforming 93.02% of the companies in the same industry.
PL has a Quick Ratio of 4.00. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.00, PL belongs to the top of the industry, outperforming 93.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 4
PL Yearly Current Assets VS Current LiabilitesPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.11% over the past year.
Looking at the last year, PL shows a quite strong growth in Revenue. The Revenue has grown by 16.89% in the last year.
PL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.62% yearly.
EPS 1Y (TTM)42.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)16.89%
Revenue growth 3Y23.03%
Revenue growth 5Y20.62%
Sales Q2Q%32.62%

3.2 Future

Based on estimates for the next years, PL will show a very strong growth in Earnings Per Share. The EPS will grow by 25.79% on average per year.
The Revenue is expected to grow by 24.36% on average over the next years. This is a very strong growth
EPS Next Y49.97%
EPS Next 2Y31.19%
EPS Next 3Y25.79%
EPS Next 5YN/A
Revenue Next Year22.01%
Revenue Next 2Y23.81%
Revenue Next 3Y24.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PL Yearly Revenue VS EstimatesPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
PL Yearly EPS VS EstimatesPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

PL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PL Price Earnings VS Forward Price EarningsPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as PL.
Industry RankSector Rank
P/FCF 170.46
EV/EBITDA N/A
PL Per share dataPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A more expensive valuation may be justified as PL's earnings are expected to grow with 25.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.19%
EPS Next 3Y25.79%

0

5. Dividend

5.1 Amount

No dividends for PL!.
Industry RankSector Rank
Dividend Yield 0%

PLANET LABS PBC

NYSE:PL (12/26/2025, 8:10:09 PM)

After market: 19.25 -0.11 (-0.57%)

19.36

-0.96 (-4.72%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)12-10 2025-12-10/amc
Earnings (Next)03-18 2026-03-18/amc
Inst Owners76.54%
Inst Owner Change25.25%
Ins Owners1.76%
Ins Owner Change-1.77%
Market Cap5.96B
Revenue(TTM)282.46M
Net Income(TTM)-129.56M
Analysts80
Price Target17.78 (-8.16%)
Short Float %10.64%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.19%
Min EPS beat(2)30.37%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)3.11%
Min EPS beat(4)-217.93%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)13.5%
EPS beat(12)11
Avg EPS beat(12)16.08%
EPS beat(16)13
Avg EPS beat(16)8.61%
Revenue beat(2)2
Avg Revenue beat(2)8.98%
Min Revenue beat(2)8.38%
Max Revenue beat(2)9.58%
Revenue beat(4)3
Avg Revenue beat(4)4.46%
Min Revenue beat(4)-3.41%
Max Revenue beat(4)9.58%
Revenue beat(8)3
Avg Revenue beat(8)0.49%
Revenue beat(12)3
Avg Revenue beat(12)-0.65%
Revenue beat(16)5
Avg Revenue beat(16)0.26%
PT rev (1m)29.69%
PT rev (3m)95.84%
EPS NQ rev (1m)-2.43%
EPS NQ rev (3m)1.13%
EPS NY rev (1m)4.07%
EPS NY rev (3m)4.82%
Revenue NQ rev (1m)5.89%
Revenue NQ rev (3m)6.08%
Revenue NY rev (1m)5.05%
Revenue NY rev (3m)5.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.11
P/FCF 170.46
P/OCF 55.5
P/B 17.05
P/tB 36.35
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.11
FCFY0.59%
OCF(TTM)0.35
OCFY1.8%
SpS0.92
BVpS1.14
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.71%
ROE -37.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.95%
FCFM 12.38%
ROA(3y)-20.33%
ROA(5y)-21.9%
ROE(3y)-27.72%
ROE(5y)-44.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.26%
GM growth 5YN/A
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 12.76
Debt/EBITDA N/A
Cap/Depr 177.2%
Cap/Sales 25.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4
Quick Ratio 4
Altman-Z 3.96
F-Score5
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)79.23%
Cap/Depr(5y)63.85%
Cap/Sales(3y)16.05%
Cap/Sales(5y)17.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y49.97%
EPS Next 2Y31.19%
EPS Next 3Y25.79%
EPS Next 5YN/A
Revenue 1Y (TTM)16.89%
Revenue growth 3Y23.03%
Revenue growth 5Y20.62%
Sales Q2Q%32.62%
Revenue Next Year22.01%
Revenue Next 2Y23.81%
Revenue Next 3Y24.36%
Revenue Next 5YN/A
EBIT growth 1Y34.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.46%
EBIT Next 3Y42.28%
EBIT Next 5YN/A
FCF growth 1Y137.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y283.05%
OCF growth 3YN/A
OCF growth 5YN/A

PLANET LABS PBC / PL FAQ

Can you provide the ChartMill fundamental rating for PLANET LABS PBC?

ChartMill assigns a fundamental rating of 3 / 10 to PL.


What is the valuation status of PLANET LABS PBC (PL) stock?

ChartMill assigns a valuation rating of 1 / 10 to PLANET LABS PBC (PL). This can be considered as Overvalued.


Can you provide the profitability details for PLANET LABS PBC?

PLANET LABS PBC (PL) has a profitability rating of 1 / 10.


How financially healthy is PLANET LABS PBC?

The financial health rating of PLANET LABS PBC (PL) is 5 / 10.